DNA image analysis is presently performed in many laboratories. Before general extrapolation of results between different laboratories, validation has to be performed for interlaboratory studies on DNA image analysis. The aim of this study was to establish the performance of different DNA image anal
Quality assurance issues in DNA image cytometry
β Scribed by Alberto Marchevsky; Tanya Tolmachoff; Stephen Lee
- Publisher
- John Wiley and Sons
- Year
- 1996
- Tongue
- English
- Weight
- 689 KB
- Volume
- 26
- Category
- Article
- ISSN
- 0196-4763
No coin nor oath required. For personal study only.
β¦ Synopsis
DNA image cytometry is currently used in many clinical laboratories as a prognostic tool for the study of patients with malignant neoplasms. However, quality assurance (QA) procedures for image cytometry (IC) have not been standardized. National proficiency testing programs for DNA IC are yet to be developed. We describe our QA program for DNA IC. Indicators of quality; thresholds for evaluation; methods for collection, organization, and evaluation of data; and actions recommended to deal with problems are described for each of the phases of DNA IC. They include QA procedures for sample acceptability; staining technique; instrumentation, including linearity and calibration verification; and correlation with other cytometric methods. The difficult problem of standardizing the postanalytical phase of QA is discussed. The need for a consensus conference to adopt standardized QA procedures for DNA image analysis is emphasized.
π SIMILAR VOLUMES
DNA measurements of 130 melanomas were carried out by flow cytometry (FCM) and image cytometry (ICM). ICM was applied to cytological preparations of fresh material (cICM) and to sections of formalin-hxed parallh embedded tissue (sICM). The DNA ploidy, the DNA index of GO/Gl peaks (DI), and the proli
Implementing and maintaining quality assurance (QA) and quality control (QC) systems for clinical trials is essential for sponsors to assure the integrity and reliability of clinical trials and the data obtained from clinical trials. The main points of the revised Good Clinical Practice (GCP) in Jap